Open Beta
TREN
MetriLume
TREN

US marketsATYR

SEC-sourced researchBeta

ATYR

aTYR PHARMA INC

Company comparison ↗

Data passport

CIK
0001339970
Exchange
Nasdaq
Business activity
— · SIC 2836
Financial inputs
5/6
Filing date
Oct 7, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 353,000.0000 USD; December 2024: 235,000.0000 USD; December 2025: 190,000.0000 USD353K USD0 USD0December 2023December 2024December 2025
ATYR · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2023353,000.0000Mar 5, 2026
December 2024235,000.0000Mar 5, 2026
December 2025190,000.0000Mar 5, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025190,000.0000-74,118,000.0000-61,986,000.000093,003,000.0000—Mar 5, 2026
December 2024235,000.0000-64,023,000.0000-69,119,000.000096,830,000.0000—Mar 5, 2026
December 2023353,000.0000-50,389,000.0000-33,221,000.0000——Mar 5, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$190KDecember 2025Mar 5, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$235KDecember 2024Mar 5, 202610-K
Net incomeNetIncomeLoss-$74.12MDecember 2025Mar 5, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$61.99MDecember 2025Mar 5, 202610-K
Total assetsAssets$93MDecember 2025Mar 5, 202610-K
Total liabilities————

New filings

Explore methodology ↗